REFRACTORY NON-HODGKIN LYMPHOMA

Clinical trials for REFRACTORY NON-HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY NON-HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for REFRACTORY NON-HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 12 Not yet recruiting 1 Not yet finished but already full! 15 Completed 3

New hope for tough-to-treat lymphoma patients as trial tests promising drug cocktail

Disease control Not yet recruiting

This study is testing a new combination of four drugs for adults with an aggressive type of blood cancer called diffuse large B-cell lymphoma, which has returned or not responded to standard treatments. The first part of the study will find the safest dose, and the second part wi…

Matched conditions: REFRACTORY NON-HODGKIN LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control

Last updated Mar 02, 2026 15:26 UTC

REFRACTORY NON-HODGKIN LYMPHOMA

Get alerted when new REFRACTORY NON-HODGKIN LYMPHOMA trials appear

New hope for tough-to-treat lymphoma patients as trial tests promising drug cocktail